Monoamine oxidase inhibitor-induced speech blockage

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Tricyclic antidepressants have been associated with speech blockage in prior case reports.
• The underlying mechanisms of this adverse effect are not fully understood.

Observation:

• This report details the first instance of speech blockage occurring in a patient treated with a monoamine oxidase inhibitor (MAOI).
• The patient experienced this side effect alongside notable clinical improvement.

Findings:

• Speech blockage is a potential side effect of both tricyclic antidepressants and monoamine oxidase inhibitors.
• The occurrence of speech blockage seems to be associated with therapeutic efficacy.

Implications:

• Clinicians should be aware of speech blockage as a possible side effect of MAOIs.
• Further research is warranted to elucidate the neurobiological mechanisms linking MAOIs, speech blockage, and antidepressant response.